The Valley Desk

NCT03361865 · Interventional trial

Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307)

Overall registry status Completed

Phase 3

Conditions UC (Urothelial Cancer)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov